Interestingly its the same words used "GROUND BREAKING" in 8th Sept 14 ann regarding Concussion trial.
These words are used in the article referred to
(or is it just me looking thru pink coloured glasses?)
In that ann of Sept 8th 2014
Neuren Executive Chairman Richard Treagus commented; "Given the known properties of NNZ-2566,
we are hopeful that this ground-breaking trial can demonstrate the potential for Neuren’s drug to
help mitigate the serious ramifications of concussions, which are now being recognised in civilian,
sporting and military communities around the world."
And from the ann on 17th july 14
The blinded data from the trial to date demonstrate that NNZ-2566 appears to be safe and well tolerated
and that the mortality rate to date is lower than expected
A possibility worth worth contemplating, page-2
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.57 |
Change
-0.040(0.26%) |
Mkt cap ! $1.990B | |||
| Open | High | Low | Value | Volume |
| $15.83 | $15.87 | $15.20 | $8.124M | 524.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 64 | $15.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.58 | 597 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |